CompletedPhase 3NCT00426023
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
Studying Vernal keratoconjunctivitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Campus Bio-Medico University
- Principal Investigator
- alessandro lambiase, MDUniversity of Rome Campus Bio-Medico
- Intervention
- Cyclosporine A 0,05% eye drop(drug)
- Enrollment
- 48 target
- Eligibility
- 5-50 years · All sexes
- Timeline
- 2007 – 2008
Study locations (3)
- University of Rome Campus Bio-Medico, Rome, Rome, Italy
- University of Genova, Genova, Italy
- University of Padua, Padua, Italy
Collaborators
University of Genova · University of Padova
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00426023 on ClinicalTrials.govOther trials for Vernal keratoconjunctivitis
Additional recruiting or active studies for the same condition.